Retinal toxicity found in a patient with systemic lupus erythematosus prior to 5 years of treatment with hydroxychloroquine

Rheumatology (United Kingdom)

Volumn 53, Issue 11, 2014, Pages 2001-

  Chiang, Elizabeth ^a   Jampol, Lee M ^a   Fawzi, Amani A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE;

ADULT; AUTOFLUORESCENCE; BODY WEIGHT; CASE REPORT; CAUCASIAN; DRUG WITHDRAWAL; ELECTRORETINOGRAM; EYE TOXICITY; HUMAN; KIDNEY FAILURE; LETTER; LONG TERM CARE; MALE; RECOMMENDED DRUG DOSE; RETINA INJURY; RETINA MACULOPATHY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION; VISUAL ACUITY; VISUAL FIELD DEFECT; YOUNG ADULT;

EID: 84911463857     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu317     Document Type: Letter

References (2)

1. Marmor MF, Kellner U, Lai TY et al. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 2011;118:415-22.
2. Mititelu M, Wong BJ, Brenner M et al. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging. JAMA Ophthalmol 2013;131:1187-97.